Welcome to LookChem.com Sign In|Join Free

CAS

  • or

57280-22-5

Post Buying Request

57280-22-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

57280-22-5 Usage

Chemical Properties

Clear colorless to yellow liquid

Uses

4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane is used in the CO2-mediated formation of chiral carbamates from meso-epoxides via polycarbonate intermediates and amine nucleophiles, which opens up a wide a wide range of CO2-based carbamate scaffolds with excellent yields and 99% enantiomeric excess.

Check Digit Verification of cas no

The CAS Registry Mumber 57280-22-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,8 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 57280-22:
(7*5)+(6*7)+(5*2)+(4*8)+(3*0)+(2*2)+(1*2)=125
125 % 10 = 5
So 57280-22-5 is a valid CAS Registry Number.

57280-22-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane

1.2 Other means of identification

Product number -
Other names 3,?5,?8-?Trioxabicyclo[5.1.0]?octane, 4,?4-?dimethyl-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:57280-22-5 SDS

57280-22-5Synthetic route

2,2-dimethyl-4,7-dihydro-1,3-dioxepin
1003-83-4

2,2-dimethyl-4,7-dihydro-1,3-dioxepin

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

Conditions
ConditionsYield
With disodium hydrogenphosphate; dihydrogen peroxide; sodium hydroxide In methanol; water; acetonitrile at 60 - 80℃; pH=7 - 9.5; Large scale; Green chemistry;85.2%
With disodium hydrogenphosphate; 3-chloro-benzenecarboperoxoic acid In dichloromethane at 20℃; for 18h; Inert atmosphere;85%
With disodium hydrogenphosphate; dihydrogen peroxide; Hexafluoroacetone In 1,2-dichloro-ethane for 24h; Heating;83%
2,2-dimethoxy-propane
77-76-9

2,2-dimethoxy-propane

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: toluene-4-sulfonic acid / dichloromethane / 3 h / 20 °C / Inert atmosphere
2: 3-chloro-benzenecarboperoxoic acid; disodium hydrogenphosphate / dichloromethane / 18 h / 20 °C / Inert atmosphere
View Scheme
C7H13BrO3

C7H13BrO3

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

Conditions
ConditionsYield
With potassium carbonate In methanol at 20℃; for 16h;19 g
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

Trimethylenediamine
109-76-2

Trimethylenediamine

C17H34N2O6

C17H34N2O6

Conditions
ConditionsYield
In ethanol epoxide:amine=2:1;100%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

benzylamine
100-46-9

benzylamine

trans-6-benzylamino-2,2'-dimethyl-1,3-dioxocycloheptan-5-ol
1036765-71-5

trans-6-benzylamino-2,2'-dimethyl-1,3-dioxocycloheptan-5-ol

Conditions
ConditionsYield
Stage #1: benzylamine With titanium(IV) isopropylate; (R)-1,1'-Bi-2-naphthol; (R)-6,6'-dibromo-1,1'-binaphth-2-ol In toluene at 20℃; for 0.5h;
Stage #2: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane With water In toluene at 40℃; for 12h; optical yield given as %ee;
99%
With titanium(IV) isopropylate; (R)-1,1'-Bi-2-naphthol In toluene enantioselective reaction;78%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

benzylamine
100-46-9

benzylamine

(5R,6S)-6-(benzylamino)-2,2-dimethyl-1,3-dioxepan-5-ol

(5R,6S)-6-(benzylamino)-2,2-dimethyl-1,3-dioxepan-5-ol

Conditions
ConditionsYield
With C92H72N2O6*2Ti*2O In water; toluene at 40℃; for 18h; Reagent/catalyst; Inert atmosphere; Green chemistry;99%
Stage #1: benzylamine With titanium(IV) isopropylate; C20H24O2; (R)-3,3'-diiodo-2,2'-dihydroxy-1,1'-binaphthyl In toluene at 20℃; for 0.5h;
Stage #2: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane With water In toluene at 40℃; for 12h; optical yield given as %ee;
27%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

1,4,7-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane
122555-91-3

1,4,7-tris-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane

1,4,7-tris(tert-butoxycarbonylmethyl)10-(6-hydroxy-2,2-dimethyl-1,3-dioxepane-5yl)-1,4,7,10-tetraazacyclododecane

1,4,7-tris(tert-butoxycarbonylmethyl)10-(6-hydroxy-2,2-dimethyl-1,3-dioxepane-5yl)-1,4,7,10-tetraazacyclododecane

Conditions
ConditionsYield
With potassium carbonate In isopropyl alcohol at 60℃; for 12h; Reagent/catalyst; Temperature;99%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

ethylenediamine
107-15-3

ethylenediamine

6-(2-Amino-ethylamino)-2,2-dimethyl-[1,3]dioxepan-5-ol

6-(2-Amino-ethylamino)-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
In ethanol epoxide:amine=1:1; addition of epoxide to amine dropwise over 1 h;98%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

thiophenol
108-98-5

thiophenol

(2R*,3R*)-1,4-di-O-isopropylidene-3-phenylthio-1,2,4-butanetriol

(2R*,3R*)-1,4-di-O-isopropylidene-3-phenylthio-1,2,4-butanetriol

Conditions
ConditionsYield
With sodium hydride In tetrahydrofuran 0 deg C, 30 min, reflux, 1 h;96.9%
bis(3-aminopropyl)amine
56-18-8

bis(3-aminopropyl)amine

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

6-[3-(3-Amino-propylamino)-propylamino]-2,2-dimethyl-[1,3]dioxepan-5-ol

6-[3-(3-Amino-propylamino)-propylamino]-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
In ethanol epoxide:amine=1:1; addition of epoxide to amine dropwise over 1 h;92%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

isopropylamine
75-31-0

isopropylamine

6-(isopropylamino)-2,2-dimethyl-1,3-dioxepan-5-ol
1036765-73-7

6-(isopropylamino)-2,2-dimethyl-1,3-dioxepan-5-ol

Conditions
ConditionsYield
Stage #1: isopropylamine With titanium(IV) isopropylate; (R)-1,1'-Bi-2-naphthol In toluene at 20℃;
Stage #2: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane With water In toluene at 40℃; for 12h; optical yield given as %ee;
91%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

(5S,6S)-6-Iodo-2,2-dimethyl-[1,3]dioxepan-5-ol

(5S,6S)-6-Iodo-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
With lithium iodide for 15h; Ambient temperature;90%
With silica gel; lithium iodide for 0.25h; Ambient temperature;90%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

trans-2,2-Dimethyl-6-hydroxy-5-amino-1,3-dioxepane
188923-20-8

trans-2,2-Dimethyl-6-hydroxy-5-amino-1,3-dioxepane

Conditions
ConditionsYield
With ammonia In water87%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

tert-butylamine
75-64-9

tert-butylamine

6-(tert-butylamino)-2,2-dimethyl-1,3-dioxepan-5-ol
1036765-74-8

6-(tert-butylamino)-2,2-dimethyl-1,3-dioxepan-5-ol

Conditions
ConditionsYield
Stage #1: tert-butylamine With titanium(IV) isopropylate; (R)-1,1'-Bi-2-naphthol In toluene at 20℃;
Stage #2: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane With water In toluene at 40℃; for 48h; optical yield given as %ee;
85%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

1,4,7-tris(tert-butyloxycarbonyl)-1,4,7,10-tetraazacyclododecane
175854-39-4

1,4,7-tris(tert-butyloxycarbonyl)-1,4,7,10-tetraazacyclododecane

C12H28N4O3

C12H28N4O3

Conditions
ConditionsYield
Stage #1: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane; 1,4,7-tris(tert-butyloxycarbonyl)-1,4,7,10-tetraazacyclododecane With lithium chloride In isopropyl alcohol for 20h; Reflux;
Stage #2: With hydrogenchloride In water; isopropyl alcohol at 60℃; for 2h;
85%
bromobenzene
108-86-1

bromobenzene

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

(5S,6R)-2,2-dimethyl-6-phenyl-1,3-dioxepan-5-ol

(5S,6R)-2,2-dimethyl-6-phenyl-1,3-dioxepan-5-ol

Conditions
ConditionsYield
With [2,2]bipyridinyl; manganese; (1,2-dimethoxyethane)dichloronickel(II); bis(η5((1R,2S,5R)-5-methyl-2-[prop-2-yl]-cyclohex-1-yl)cyclopentadienyl)-titanium dichloride; triethylamine hydrochloride at 20℃; for 12h; Inert atmosphere; Glovebox; Autoclave; enantioselective reaction;82%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

(5S,6S)-6-Bromo-2,2-dimethyl-[1,3]dioxepan-5-ol

(5S,6S)-6-Bromo-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
With lithium bromide for 8h; Ambient temperature;80%
With silica gel; lithium bromide for 8h; Ambient temperature;80%
1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt

1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

2,2',2
138168-36-2

2,2',2"-(10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid

Conditions
ConditionsYield
Stage #1: 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt; 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane In isopropyl alcohol for 10h; Inert atmosphere; Reflux; Industrial scale;
Stage #2: With hydrogenchloride In water for 1h; Solvent; Industrial scale;
80%
1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt

1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt

gadolinium(III) chloride

gadolinium(III) chloride

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

gadolinium complex of 10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid

gadolinium complex of 10-[2,3-dihydroxy-1-(hydroxymethyl)propyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid

Conditions
ConditionsYield
Stage #1: 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt; 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane With hydrogenchloride In water at 40 - 80℃; for 12h;
Stage #2: gadolinium(III) chloride In water at 50℃; for 1h;
Stage #3: With hydrogenchloride; sodium hydroxide more than 3 stages;
79.1%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

lithium cyanide
2408-36-8

lithium cyanide

(+/-)-trans-6-hydroxy-2,2-dimethyl-1,3-dioxepane-5-carbonitrile
141077-78-3

(+/-)-trans-6-hydroxy-2,2-dimethyl-1,3-dioxepane-5-carbonitrile

Conditions
ConditionsYield
In tetrahydrofuran for 3h; Heating;79%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

trimethylsilan
993-07-7

trimethylsilan

carbon monoxide
201230-82-2

carbon monoxide

2,2-Dimethyl-5-trimethylsilanyloxy-6-trimethylsilanyloxymethyl-[1,3]dioxepane

2,2-Dimethyl-5-trimethylsilanyloxy-6-trimethylsilanyloxymethyl-[1,3]dioxepane

Conditions
ConditionsYield
dicobalt octacarbonyl In toluene at 25℃; under 760 Torr; for 20h;77%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

(5S,6S)-6-Chloro-2,2-dimethyl-[1,3]dioxepan-5-ol

(5S,6S)-6-Chloro-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
With water; silica gel; lithium chloride for 96h; Ambient temperature;76%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

1,4,7,10-tetraazacyclododecan
294-90-6

1,4,7,10-tetraazacyclododecan

3-(1,4,7,10-tetraazacyclododecane-1-yl)butane-1,2,4-triol tetrahydrochloride

3-(1,4,7,10-tetraazacyclododecane-1-yl)butane-1,2,4-triol tetrahydrochloride

Conditions
ConditionsYield
Stage #1: 4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane; 1,4,7,10-tetraazacyclododecan With lithium chloride In isopropyl alcohol at 85 - 95℃; Large scale;
Stage #2: With hydrogenchloride In methanol for 3h; Reflux; Large scale;
73.4%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

4,4-dimethyl-3,5-dioxacycloheptanol
141509-49-1

4,4-dimethyl-3,5-dioxacycloheptanol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether for 24h; Ambient temperature;68%
4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane
57280-22-5

4,4-dimethyl-3,5,8-trioxabicyclo[5.1.0]-octane

1,5-diamino-3-azapentane
111-40-0

1,5-diamino-3-azapentane

6-[2-(2-Amino-ethylamino)-ethylamino]-2,2-dimethyl-[1,3]dioxepan-5-ol

6-[2-(2-Amino-ethylamino)-ethylamino]-2,2-dimethyl-[1,3]dioxepan-5-ol

Conditions
ConditionsYield
In ethanol epoxide:amine=1:1; addition of epoxide to amine dropwise over 1 h;67%

57280-22-5Relevant articles and documents

Divergent approach to the synthesis of (-)-balanol heterocycle and cis-3-hydroxypipecolic acid based on chiral 2-aminoalkanol equivalent

Chavan, Subhash P.,Kalbhor, Dinesh B.,Gonnade, Rajesh G.

, (2021/01/14)

Enantioselective synthesis of the hexahydroazepine core of (?)-balanol and formal synthesis of cis-3-hydroxypipecolic acid from a common intermediate have been accomplished by a divergent path. The common intermediate was accessed from a favorably protected enantiomerically pure 2-amino-1,3,4-butanetriol (ABT) equivalent via oxidation and Wittig olefination. The synthesis of (?)-balanol heterocycle featured tandem reduction/acetal-deprotection/γ-lactonization reaction and a one-pot azide reduction followed by seven membered aza-heterocycle formation while the route to cis-3-hydroxypipecolic acid highlighted the base induced piperidine ring formation and regioselective benzylidine-acetal cleavage.

Preparation process method of gadobutrol epoxy side chain intermediate

-

Paragraph 0070; 0137-0145, (2017/08/29)

The invention disclose a 4,4-dimethyl 3,5,8-trioxabic [5,1,0]ycloctane and particularly relates to a preparation process method of a gadobutrol epoxy side chain intermediate. According to the preparation process method disclosed by the invention, by adjusting the weight ratio of feeding materials, optimizing reaction conditions and improving post treatment and purification methods, the impurity content of an obtained gadobutrol epoxy side chain intermediate product is low; the quality of the intermediate product is greatly improved while the yield is increased, so that the difficulty of process control of the gadobutrol crude drugs during the production process is reduced, and the quality and the qualification rate of the gadobutrol crude drugs are improved. The preparation process method disclosed by the invention has the advantages of simple operation methods in all process steps, safe and feasible solvent and technological conditions, realization of green and environmental-friendly production and wide application prospect.

Production method of optically active amino alcohols

-

, (2008/06/13)

A method for producing an optically active amino alcohol compound of the formula [3], an enantiomer thereof or a salt thereof, comprising reacting a mesoepoxide compound of the formula [1] with a compound of the formula [2] in the presence of a mixed catalyst comprising a Lewis acid and a proton donor: wherein R1, R2and R3are each H, an optionally substituted lower alky, and the like, or R1and R1or R2and R3may form an optionally substituted ring; and R4and R5are each H, an optionally substituted lower alkyl, and the like, or R4and R5may form an optionally substituted ring together with the adjacent N, or an imide group or azide group together with the adjacent N, and R6is H or a silyl group. The present invention enables stereoselective production of a desired intermediate compound, which is an HIV protease inhibitor, extremely efficiently as compared to conventional methods. The method of the present invention is a very useful method which can be used not only for the production of said intermediate compound but also for the production of various other compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 57280-22-5